Miragen Therapeutics Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Miragen Therapeutics Inc in the second quarter 2026?
Miragen Therapeutics Inc recorded a cumulative net loss of $-240 million during 12 months ending in the second quarter 2026, resulting in a negative return on equity (ROE) of -78.65%.

Within the Medical Laboratories industry 32 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2025 from 3871 to 3989.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jun 30 2026) II. Quarter	(Jun 30 2025) II. Quarter	(Sep 30 2020) III. Quarter	(Jun 30 2020) II. Quarter	(Dec 31 2019) IV. Quarter
Y / Y Equity Change	4102.72 %	2123.53 %	-37.07 %	-48.31 %	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	-240	-123	-33	-37	-42
Return On Equity (TTM)	-78.65 %	-85.69 %	-164.06 %	-156.86 %	-147.81 %
MGEN's Total Ranking	# 3989	# 3871	#	#	#
Equity (TTM) in Millions	662	515	21	21	16
Seq. Equity Change	28.52 %	2348.29 %	-0.61 %	34.38 %	-32 %
Seq. Net Income Change	-	-	-	-	-

Back to MGEN Management Effectiveness >> MGEN's 5 Years Annual ROE >> Compare MGEN ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 33
Sector	# 649
Overall	# 3989

Return On Equity Statistics
High	Average	Low
-46.99 %	-102.03 %	-228.42 %
(Jun 30 2018)		(Sep 30 2019)

MGEN Annual Return On Equity	(Dec 31 2019) 2019	(Dec 31 2018) 2018	(Dec 31 2017) 2017	(Dec 31 2016) 2016	(Dec 31 2015) 2015
Total Equity in Millions	16	0	0	0	0
Y / Y Equity Change	-	-	-	-	-
Net Income in Millions	-42	-33	-27	-13	-11
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-265.79 %	-	-	-	-

Back to MGEN Management Effectiveness >> MGEN's 5 Years Annual ROE >> Compare MGEN ROE to its Competitors

More Return On Equity Ratios
Medical Laboratories Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
MGEN's' Return on Equity at Yahoo Finance
MGEN's Roe Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for MGEN's Competitors
Subscribers only: Roe for Miragen Therapeutics Inc 's Suppliers
Subscribers only: Return On Equity for MGEN's Customers

Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector

ROE

Date modified: 2026-09-12T06:14:45+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.